Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2b (Pegbene) + tenofovir vs tenofovir in chronic hepatitis B
CTR20191917Phase 3Completed
- Sponsor
- Tebao Biotech
- Start
- Nov 2019
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB), sponsored by Tebao Biotech. Started Nov 2019; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20191917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191917.